- Civil szervezet
Beren Therapeutics
Biopharmaceutical company developing transformative medicines
Bemutatkozás
Beren Therapeutics is a public benefit corporation founded to serve patients through transformative medicines. It advances biology and chemistry to address the root cause of diseases, working in partnership with patients, caregivers, clinicians and health systems. Its lead investigational drug, adrabetadex, is being studied in children with infantile-onset Niemann-Pick disease, type C. The company also runs the 'Test for NPC' initiative to help identify undiagnosed people with Niemann-Pick disease, type C.
Szolgáltatások, tevékenységek
- Investigational medicines development
- Adrabetadex clinical development
- NPC diagnostic testing initiative